First Trust NYSE Arca Biotechnology Index Fund
157 hedge funds and large institutions have $726M invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+3
Holders Change %
+1.95%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
23
Increased
56
Reduced
38
Closed
19
Calls
$4.48M
Puts
$1.72M
Net Calls
+$2.76M
Net Calls Change
+$102K
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$12.5M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.95M |
| 3 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
+$8.24M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$8.03M |
| 5 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
+$7.56M |
Top Sellers
| 1 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
-$7.82M |
| 2 |
Goldman Sachs
New York
|
-$3.43M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.11M |
| 4 |
SAM
Silphium Asset Management
London,
United Kingdom
|
-$1.99M |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$1.2M |
